MustGrow Biologics Corp. (TSXV:MGRO)
Canada · Delayed Price · Currency is CAD 0.5100
+0.0200 (4.08%)
Jun 3, 2026, 9:30 AM EST
MustGrow Biologics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.6 | 8.29 | 0.13 | 4.71 | 0.01 | 0.01 | |
Revenue Growth (YoY) | 3567.20% | 6501.87% | -97.34% | 72630.36% | -49.65% | - |
Cost of Revenue | 3.66 | 6.82 | 0.1 | - | - | - |
Gross Profit | 0.78 | 1.46 | 0.03 | 4.71 | 0.01 | 0.01 |
Selling, General & Admin | 5.35 | 6.37 | 4.07 | 3.96 | 4.82 | 2.29 |
Depreciation & Amortization Expenses | 0.04 | 0.05 | - | - | - | - |
Research & Development | 0.48 | 0.47 | 0.77 | 0.86 | 0.48 | 0.46 |
Other Operating Expenses | 0.71 | 1.54 | 0.57 | 0.7 | 0.4 | 0.28 |
Total Operating Expenses | 6.58 | 8.44 | 5.41 | 5.52 | 5.69 | 3.03 |
Operating Income | -6.36 | -6.98 | -5.11 | -0.8 | -5.69 | -3.01 |
Interest Income | 0.02 | 0.03 | 0.2 | 0.21 | 0.1 | 0 |
Interest Expense | -0.14 | -0.31 | - | - | -0.01 | -0.05 |
Other Non-Operating Income (Expense) | -0.01 | 0 | 0.02 | -0.08 | 0.03 | -0 |
Total Non-Operating Income (Expense) | -0.13 | -0.28 | 0.23 | 0.13 | 0.12 | -0.05 |
Pretax Income | -6.49 | -7.26 | -4.89 | -0.68 | -5.57 | -3.06 |
Net Income | -6.94 | -7.26 | -4.89 | -0.68 | -5.57 | -3.06 |
Earnings From Discontinued Operations | -0.45 | - | - | - | - | - |
Net Income to Common | -6.94 | -7.26 | -4.89 | -0.68 | -5.57 | -3.06 |
Shares Outstanding (Basic) | 57 | 54 | 52 | 50 | 49 | 44 |
Shares Outstanding (Diluted) | 59 | 54 | 52 | 50 | 49 | 44 |
Shares Change (YoY) | 13.77% | 5.35% | 3.41% | 1.80% | 12.06% | 17.22% |
EPS (Basic) | -0.11 | -0.13 | -0.09 | -0.01 | -0.11 | -0.07 |
EPS (Diluted) | -0.11 | -0.13 | -0.09 | -0.01 | -0.11 | -0.07 |
Shares Outstanding | 61.93 | 54.35 | 51.6 | 49.89 | 49.66 | 47.78 |
Free Cash Flow | -3.79 | -5.06 | -3.58 | -0.29 | -3.26 | -2.41 |
Free Cash Flow Per Share | -0.06 | -0.09 | -0.07 | -0.01 | -0.07 | -0.06 |
Gross Margin | 16.84% | 17.65% | 22.51% | 100.00% | 100.00% | 100.00% |
Operating Margin | -138.19% | -84.22% | -4074.45% | -17.08% | -87746.90% | -23409.00% |
Profit Margin | -169.71% | -87.58% | -3894.84% | -14.37% | -85905.90% | -23808.20% |
FCF Margin | -82.40% | -61.05% | -2850.82% | -6.26% | -50278.40% | -18741.00% |
EBITDA | -6.32 | -6.93 | -5.11 | -0.8 | -5.69 | -3.01 |
EBITDA Margin | -137.35% | -83.61% | -4074.45% | -17.08% | -87746.90% | -23409.00% |
EBIT | -6.36 | -6.98 | -5.11 | -0.8 | -5.69 | -3.01 |
EBIT Margin | -138.19% | -84.22% | -4074.45% | -17.08% | -87746.90% | -23409.00% |